MEP37508A - Process for the preparation of mesylates of piperazine derivatives - Google Patents

Process for the preparation of mesylates of piperazine derivatives

Info

Publication number
MEP37508A
MEP37508A MEP-375/08A MEP37508A MEP37508A ME P37508 A MEP37508 A ME P37508A ME P37508 A MEP37508 A ME P37508A ME P37508 A MEP37508 A ME P37508A
Authority
ME
Montenegro
Prior art keywords
mesylates
preparation
piperazine derivatives
relates
piperazine
Prior art date
Application number
MEP-375/08A
Other languages
Bosnian (bs)
English (en)
Croatian (hr)
Inventor
Marcel P M Van Aar
Stefanus J Schouten
Jan Zorgdrager
Michiel C Heslinga
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of MEP37508A publication Critical patent/MEP37508A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
MEP-375/08A 2001-02-16 2002-02-14 Process for the preparation of mesylates of piperazine derivatives MEP37508A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01200534 2001-02-16
PCT/EP2002/001666 WO2002066449A2 (en) 2001-02-16 2002-02-14 Process for the preparation of mesylates of piperazine derivatives

Publications (1)

Publication Number Publication Date
MEP37508A true MEP37508A (en) 2011-02-10

Family

ID=8179894

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-375/08A MEP37508A (en) 2001-02-16 2002-02-14 Process for the preparation of mesylates of piperazine derivatives

Country Status (35)

Country Link
US (1) US7030241B2 (es)
EP (1) EP1362040B1 (es)
JP (1) JP4328528B2 (es)
KR (2) KR100859106B1 (es)
CN (1) CN1176079C (es)
AR (1) AR034206A1 (es)
AT (1) ATE284875T1 (es)
AU (1) AU2002250962B2 (es)
BG (1) BG66101B1 (es)
BR (1) BR0205683A (es)
CA (1) CA2422703C (es)
CZ (1) CZ301780B6 (es)
DE (1) DE60202261T2 (es)
DK (1) DK1362040T3 (es)
DZ (1) DZ3489A1 (es)
ES (1) ES2230481T3 (es)
HK (1) HK1059934A1 (es)
HR (1) HRP20030610B1 (es)
HU (1) HUP0400772A3 (es)
IL (1) IL153509A (es)
IS (1) IS2417B (es)
ME (1) MEP37508A (es)
MX (1) MXPA03002359A (es)
MY (1) MY130687A (es)
NO (1) NO324460B1 (es)
NZ (1) NZ524632A (es)
PL (1) PL208363B1 (es)
PT (1) PT1362040E (es)
RS (1) RS51126B (es)
RU (1) RU2272036C2 (es)
SI (1) SI1362040T1 (es)
SK (1) SK286143B6 (es)
UA (1) UA75390C2 (es)
WO (1) WO2002066449A2 (es)
ZA (1) ZA200301590B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR045362A1 (es) * 2003-08-18 2005-10-26 Solvay Pharm Bv Forma cristalina estable de mesilato de bifeprunox (monometansulfonato de 7-[4-([1,1- bifenil] -3- ilmetil) -1- piperazinil] - 2-(3h) -benzoxazolona
US7435738B2 (en) 2003-08-18 2008-10-14 Solvay Pharmaceuticals, Inc. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
US7405216B2 (en) * 2004-08-18 2008-07-29 Solvay Pharmaceuticals, B.V. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
US7423040B2 (en) * 2005-02-18 2008-09-09 Irene Eijgendaal Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same
US7964604B2 (en) * 2005-02-18 2011-06-21 Solvay Pharmaceuticals B.V. Bifeprunox mesylate maintenance dose compositions and methods for using the same
US20070275977A1 (en) * 2006-05-02 2007-11-29 Van Aar Marcel P N-oxides of pyridylmethyl -piperazine and -piperidine derivatives
US8106056B2 (en) * 2006-06-16 2012-01-31 Solvay Pharmaceuticals B.V. Combination preparations comprising bifeprunox and a dopamine agonist
US7786126B2 (en) * 2006-06-16 2010-08-31 Solvay Pharmaceuticals B.V. Combination preparations comprising SLV308 and a dopamine agonist
KR20090063228A (ko) 2006-08-31 2009-06-17 솔베이 파마슈티칼스 비. 브이 정신분열증 치료용 비페프루녹스를 위한 적정 계획 및 이에사용하기 위한 키트
US20090068290A1 (en) * 2006-08-31 2009-03-12 Michel Bourin Bifeprunox doses for treating schizophrenia
US20080132520A1 (en) * 2006-08-31 2008-06-05 Winsemius Antje A Compositions, kits and methods for administering a titration schedule comprising bifeprunox compounds
CN101939009B (zh) 2008-02-05 2013-07-17 哈博生物科学公司 药学固体形式
WO2011023796A1 (en) 2009-08-31 2011-03-03 Abbott Healthcare Products B.V. Bifeprunox for treating addiction
UY32934A (es) 2009-10-12 2011-05-31 Abbott Healthcare Products Bv Monohidrato de pardoprunox

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE81975T1 (de) 1984-12-21 1992-11-15 Duphar Int Res Arzneimittel mit psychotroper wirkung.
DE3571436D1 (en) 1984-12-21 1989-08-17 Duphar Int Res New pharmaceutical compositions having anti-psychotic properties
JPH0344383A (ja) * 1989-07-12 1991-02-26 Ihara Chem Ind Co Ltd 5―トリフルオロメチル―2―ハロメチルベンゾチアゾール類の製造法
JP3044383B2 (ja) * 1990-05-22 2000-05-22 コニカ株式会社 含窒素6員環化合物の製造方法
NZ331860A (en) * 1996-03-29 2000-04-28 Duphar Int Res Piperazine and piperidine compounds with affinity for both dopamine D2 and seratonin 5-HT1A receptors
SE9702799D0 (sv) 1997-07-25 1997-07-25 Astra Ab New compounds
UA71590C2 (en) 1998-11-13 2004-12-15 Duphar Int Res Piperazine and piperidine derivatives
US7435738B2 (en) 2003-08-18 2008-10-14 Solvay Pharmaceuticals, Inc. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)

Also Published As

Publication number Publication date
NO20031754L (no) 2003-04-15
CZ301780B6 (cs) 2010-06-23
JP2004518741A (ja) 2004-06-24
IS6876A (is) 2003-07-17
AU2002250962B2 (en) 2006-08-24
BG108090A (bg) 2004-12-30
NO324460B1 (no) 2007-10-22
PT1362040E (pt) 2005-05-31
BG66101B1 (bg) 2011-04-29
IL153509A (en) 2007-12-03
IS2417B (is) 2008-10-15
BR0205683A (pt) 2004-07-06
KR101000733B1 (ko) 2010-12-14
AR034206A1 (es) 2004-02-04
SI1362040T1 (en) 2005-06-30
HK1059934A1 (en) 2004-07-23
WO2002066449A3 (en) 2002-10-24
NO20031754D0 (no) 2003-04-15
MY130687A (en) 2007-07-31
DE60202261T2 (de) 2005-05-19
RU2272036C2 (ru) 2006-03-20
PL208363B1 (pl) 2011-04-29
SK3092003A3 (en) 2003-09-11
SK286143B6 (sk) 2008-04-07
DE60202261D1 (de) 2005-01-20
JP4328528B2 (ja) 2009-09-09
NZ524632A (en) 2004-03-26
HRP20030610B1 (en) 2006-02-28
EP1362040B1 (en) 2004-12-15
UA75390C2 (en) 2006-04-17
CA2422703C (en) 2010-04-13
ZA200301590B (en) 2004-02-05
ES2230481T3 (es) 2005-05-01
US20040077631A1 (en) 2004-04-22
EP1362040A2 (en) 2003-11-19
HUP0400772A3 (en) 2008-02-28
US7030241B2 (en) 2006-04-18
CZ2003697A3 (cs) 2003-06-18
IL153509A0 (en) 2003-07-06
DK1362040T3 (da) 2005-01-24
WO2002066449A2 (en) 2002-08-29
ATE284875T1 (de) 2005-01-15
DZ3489A1 (fr) 2002-08-29
HRP20030610A2 (en) 2005-06-30
RS51126B (sr) 2010-10-31
KR20030077523A (ko) 2003-10-01
CN1176079C (zh) 2004-11-17
KR20080064206A (ko) 2008-07-08
YU64403A (sh) 2006-05-25
CN1463268A (zh) 2003-12-24
MXPA03002359A (es) 2003-06-30
CA2422703A1 (en) 2002-08-29
PL369330A1 (en) 2005-04-18
KR100859106B1 (ko) 2008-09-18
HUP0400772A2 (hu) 2004-08-30

Similar Documents

Publication Publication Date Title
MEP37508A (en) Process for the preparation of mesylates of piperazine derivatives
IL161559A0 (en) Dibenzylamine derivatives and pharmaceutical compositions containing the same
CO5611127A2 (es) Derivados de indolilmaleimida
NO20051826L (no) Heterosyklisk substituerte piperaziner for behandling av schizofreni
HUP0401982A2 (hu) Indolizinszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények
RS20050380A (en) 3-amino piperidine derivatives and methods of manufacture
NO20060219L (no) Forbindelser
YU52403A (sh) Heterociklična jedinjenja koja imaju antibakterijsko dejstvo, postupak za njihovo dobijanje i farmaceutske smeše koje ih sadrže
WO2004103977A3 (en) Process for the preparation of pyrimidine derivatives
MXPA03000161A (es) Compuestos novedosos los cuales tienen actividad antiinflamatoria, proceso para su preparacion y composiciones farmaceuticas que las contienen.
AU2003249484A1 (en) Novel bio-active molecules
TNSN07006A1 (en) Novel heterocyclic compounds
AU6785201A (en) Novel pyrazinone derivatives
NO934652L (no) Enzymatisk prosess for stereoselektiv fremstilling av heterobicyklisk alkoholenantiomer
MXPA04000978A (es) Procedimiento para la produccion de 4-amino-2,5-bisheterociclilquinazolinas.
DK1303514T3 (da) Fremgangsmåde til fremstilling af azacycloalkanoylaminothiazoler
HRP20020440B1 (en) 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
GB0215392D0 (en) Chemical compounds
HUP0004294A2 (hu) Indolszármazékok, a vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
RS50085B (sr) Novi derivati morfolina, postupak za njihovo dobijanje i farmaceutske kompozicije koje ih sadrže
MY139258A (en) Carbamoyl-type benzofuran derivatives
EA200400469A1 (ru) Замещенные производные алкиламинопиридазинона, способ их получения и содержащие их фармацевтические композиции
MXPA03012073A (es) Amidoderivados heterociclicos.
MY134563A (en) Process for preparing distamycin derivatives
MXPA03002532A (es) Nuevos compuestos de indolina, un proceso para su preparacion y composiciones farmaceuticas que los contienen.